# HUL share price today (Hindustan Unilever Ltd, NSE: HINDUNILVR) > HUL share price today: ₹1,977.10 at the NSE close on 4 November 2026, down 14.4% in a year. Hindustan Unilever (NSE: HINDUNILVR) is worth ₹4,64,438 crore, trades at a P/E of 41.5 and has closed between ₹1,814.70 and ₹2,424.20 over the past 52 weeks. > Hindustan Unilever Ltd's earnings have grown faster than its share price. Earnings per share grew +41.2% in a year while the price moved −14.4%. HINDUNILVR · FMCG - Personal Care · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/hindustan-unilever-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Growing steadily, from the last 12 quarters - Price: ₹1,977.10 (−14.4% in a year) - P/E: 41.5× (lower than 94% of the last 11 years) - Revenue (Sep 2026): ₹18,226 Cr (+14.5% on a year ago) - Profit (Sep 2026): ₹2,796 Cr (+3.8% on a year ago) - Operating margin: 22.0% (−2.0 points on a year ago) - ROCE: 28%, FY26 - ROIC: 25.0%, against a 12.0% cost of capital: +13.0 points The main question: yearly earnings per share moved +41.2% while the share price moved −14.4%. ## What is the HUL share price today? Hindustan Unilever Ltd's share price was ₹1,977.10 at the close on 4 November 2026. It has been falling for 33 weeks. That is 5.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,815 and ₹2,424, and at that close it sat 27% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row. Over the last 11 years the share price moved +143% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at HUL this quarter? Three changes stood out: lowest operating margin in 16 quarters, foreign funds (FIIs) cut their stake for 4 quarters in a row and indian funds and insurers (DIIs) raised their stake for 4 quarters in a row. 1. Lowest operating margin in 16 quarters Operating margin was 22% in the September 2026 quarter, against 24% a year earlier. 2. Foreign funds (FIIs) cut their stake for 4 quarters in a row From 10.8% to 9.3% of the company by the September 2026 quarter. 3. Indian funds and insurers (DIIs) raised their stake for 4 quarters in a row From 15.6% to 17.1% of the company by the September 2026 quarter. ## What are HUL's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), HUL reported revenue of ₹18,226 crore, up 14.5% from ₹15,919 crore a year earlier, and a profit of ₹2,796 crore, up 3.8% from ₹2,694 crore. ### HUL results: July to September 2026 against a year earlier | Measure | July to September 2026 | July to September 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹18,226 crore | ₹15,919 crore | +14.5% | | Profit | ₹2,796 crore | ₹2,694 crore | +3.8% | | Earnings per share | ₹11.87 | ₹11.43 | +3.8% | | Operating margin | 22.0% | 24.0% | −2.0 points | The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 4 September 2026, about April to June 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.) ## What is the HUL share price history? HUL closed at ₹1,977.10 on 4 November 2026, down 14.4% from ₹2,310.37 a year earlier (7 November 2025) and down 14.7% over five years. Its highest weekly close since March 2016 was ₹2,849.77 on 20 September 2024. ### HUL share price: then and now | When | Close | Change to 4 Nov 2026 | | --- | --- | --- | | 1 week ago · 30 Oct 2026 | ₹1,864.60 | +6.0% | | 1 month ago · 1 Oct 2026 | ₹1,836.00 | +7.7% | | 6 months ago · 8 May 2026 | ₹2,287.70 | −13.6% | | 1 year ago · 7 Nov 2025 | ₹2,310.37 | −14.4% | | 3 years ago · 3 Nov 2023 | ₹2,401.53 | −17.7% | | 5 years ago · 4 Nov 2021 | ₹2,318.84 | −14.7% | | 10 years ago · 4 Nov 2016 | ₹811.60 | +143.6% | | Earliest weekly close in our records · 11 Mar 2016 | ₹815.04 | +142.6% | | Highest weekly close since March 2016 · 20 Sep 2024 | ₹2,849.77 | −30.6% | | Lowest weekly close since March 2016 · 23 Dec 2016 | ₹755.61 | +161.7% | | 52-week high (weekly close) · 6 Feb 2026 | ₹2,424.20 | −18.4% | | 52-week low (weekly close) · 23 Oct 2026 | ₹1,814.70 | +8.9% | Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (562 weekly closes from 11 March 2016 to 4 November 2026.) ## What is the latest news on HUL? 12 Nov 2026: Coming up: ex-date for an interim dividend of ₹19 a share. 4 Nov 2026: HUL closed at ₹1,977.10, up 6.0% on the week and up 7.7% on the month. ### Earlier - Results for July to September 2026: Revenue up 14.5% and profit up 3.8% on a year earlier. - 4 Sep 2026: HUL held its results call for April to June 2026. Management guided: FY27 better than FY26, with competitive volume-led revenue and profit growth. - 23 Jun 2026: ex-date for a dividend of ₹22 a share. - 7 Nov 2025: ex-date for an interim dividend of ₹19 a share. ## What dividend does HUL pay? The last was a dividend of ₹22 a share, ex-date 23 June 2026. Next: ₹19 a share, ex-date 12 November 2026. ### HUL dividends since 1 April 2021 | Ex-date | Dividend per share | Type | Record date | | --- | --- | --- | --- | | 12 Nov 2026 (upcoming) | ₹19 | Interim | same day | | 23 Jun 2026 | ₹22 | Dividend | same day | | 7 Nov 2025 | ₹19 | Interim | same day | | 23 Jun 2025 | ₹24 | Dividend | same day | | 6 Nov 2024 | ₹29 | Interim + Special | same day | | 14 Jun 2024 | ₹24 | Dividend | n/a | | 2 Nov 2023 | ₹18 | Interim | same day | | 19 Jun 2023 | ₹22 | Dividend | n/a | | 1 Nov 2022 | ₹17 | Interim | 2 Nov 2022 | | 15 Jun 2022 | ₹19 | Dividend | n/a | | 26 Oct 2021 | ₹15 | Interim | 27 Oct 2021 | | 14 Jun 2021 | ₹17 | Dividend | n/a | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. We do not print a yield for HUL: one of its dividend records from the last 12 months could not be read cleanly or matched to today’s share count, and we do not guess. Yes. Hindustan Unilever Ltd paid out 64% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 5 November 2026.) ## What did HUL management say on the latest results call? On the call for April to June 2026, held on 4 September 2026, HUL's management guided: FY27 better than FY26, with competitive volume-led revenue and profit growth. > “That is why we are raising the upper end of our EBITDA margin guidance from 23.5% to 24%.” > Niranjan Gupta, CFO, on the call for April to June 2026 ### What management guided - 40% of growth from consumption and premiumization, 40% from market making and 20% from new spaces. - Margin-accretive portfolio growth planned at 1.5x the rest; Dove planned to become HUL's number-two brand. - Capital spending to rise to 3% of turnover, with 85-90% for growth and savings programs. - Future Savings Lab to add 100 basis points over 5 years; fixed-cost growth planned at 0.7-0.8x top-line growth. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/369-04-Sep-2026.pdf). (From the call for April to June 2026, 4 September 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.) ## What to watch in HUL's next results? When HUL reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Body-wash inflection: check whether scaled sampling and education convert trial into repeat usage. - What to check (from the call) - Body-wash inflection: check whether scaled sampling and education convert trial into repeat usage. - Core-brand competitiveness: check Glow & Lovely, Lifebuoy and Wheel beyond premium-led growth. - New Foods spaces: check Horlicks Protein and Kissan chutneys for distribution, repeat purchase and category development. ## Which stock lists is HUL on? HUL is on one of our India lists: Nifty 50 companies. [Nifty 50 companies](https://www.sectoralpha.in/nifty-50-stocks-list) ## Is HUL profitable? Hindustan Unilever Ltd earned ₹2,796 Cr of net profit in the Sep 2026 quarter, +3.8% on the same quarter a year earlier. Full-year FY26 profit was ₹15,059 Cr. Over 10 years profit has grown 13.8% a year on average. That is 15.3% of the quarter's revenue. The same quarter a year earlier earned ₹2,694 Cr. For the full year, FY26 profit was ₹15,059 Cr (+41.1% on the year before). Why profit moved: revenue changed +14.5% on a year earlier and the margin moved −2.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +35.6% and revenue +9.5%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does HUL make, and is it growing? Hindustan Unilever Ltd reported ₹18,226 Cr of revenue in the Sep 2026 quarter, +14.5% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 10 years it has grown 7.2% a year on average. The last full year, FY26, came in at ₹64,468 Cr. The last four reported quarters add to ₹68,359 Cr. FY26 revenue was ₹64,468 Cr, +5.1% on the year before. Recent pace: the last four quarters grew +9.5% on average, against 7.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +9.5%, against +4.7% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +38.0%, against +21.1% a year (accelerating). ## How much of every ₹100 of sales does HUL keep? Hindustan Unilever Ltd's operating margin was 22.0% in the Sep 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 16.0% and 25.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.3 percentage points on the year while gross margin changed −4.0 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is HUL's profit turning into cash? Over the last 3 years, 107% of Hindustan Unilever Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹10,999 Cr of operating cash against ₹15,059 Cr of profit. After ₹4,297 Cr of spending on assets, ₹6,702 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 107% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 2.2× depreciation over three years. The next section checks what that spending is building. ## Where does HUL's cash go? Hindustan Unilever Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −89 days in FY26, down from −83 days in FY21. It spent ₹8,300 Cr on assets over the last 3 years. Customers take 19 days to pay, and stock sits for 61 days on average. At FY26 sales of ₹64,468 Cr, each day of that cycle ties up about ₹177 Cr, so roughly −₹15,720 Cr is tied up in the business at any time. FY26: customers took 19 days to pay and stock sat for 61 days, about 2.0 months of sales sitting as stock, for a full cycle of −89 days, shorter than FY21's −83. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 61 days. Customers pay about 19 days after that. Suppliers are paid at 169 days. Together that makes the −89-day cycle. Spending on assets: ₹8,300 Cr over the last 3 years, against ₹3,802 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹880 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is HUL's P/E ratio, and how does it compare with its own history? Hindustan Unilever Ltd's P/E is 41.5×, near the low end of its own history: it has been lower only 6% of the time. Its usual P/E (the middle reading) is 58.2×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹64.10. Why the multiple is where it is: over the past year earnings per share moved +41.2% while the price moved −14.4%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −3.1% a year; about +5.8% a year came from earnings growth and about −8.9 percentage points from the multiple (the market paying less); over 10 years the price moved +9.3% a year; about +9.5% a year came from earnings growth and about −0.2 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the HUL business getting better or worse? Hindustan Unilever Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 30.0%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## How much does HUL earn on its capital? Hindustan Unilever Ltd earned a ROCE of 28% in FY26. That is up from a low of 25% in FY22. Its return on capital used (ROIC) is 13.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 23.4% net margin and 0.81× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 23.4% net margin × 0.81× asset turnover × 1.64× leverage (assets divided by equity) ≈ 31.1% on equity. The margin does most of the work; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 25.0% − 12.0% = +13.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. ## Does HUL have too much debt? Hindustan Unilever Ltd has total debt of ₹1,672 Cr against shareholder equity of ₹49,111 Cr as of Sep 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.02 in FY22 to 0.03 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the HUL shareholding pattern? Foreign institutions cut their stake in Hindustan Unilever Ltd by 2.9 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 9.3% of the company. Domestic institutions moved +2.9 points over the same period, to 17.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −2.9 points over 8 quarters, to 9.3%; Domestic institutions: +2.9 points over 8 quarters, to 17.1%; Promoters: +0.0 points over 8 quarters, to 61.9%. Why the owners changed: foreign institutions moved −2.9 points and domestic institutions +2.9 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is HUL from balance-sheet trouble? For Hindustan Unilever Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does HUL rank in its industry? 69.2 out of 100, rank 2 of 12 in FMCG - Personal Care, with 100% of the evidence available. Hindustan Unilever Ltd scores 69.2 out of 100 against the 12 companies it is compared with in FMCG - Personal Care, ranking 2. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 23.4 + 15.8 + 17.2 + 12.8 = 69.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is HUL compared with? HUL ranks 2 of 12 FMCG - Personal Care companies on the 4-Factor Sector Score, with 69.2 out of 100. 1. [Bajaj Consumer Care Ltd](https://www.sectoralpha.in/stocks/bajaj-consumer-care-ltd) BAJAJCON · quiet · Most evidence points up · 100% evidence 69.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 28% · Profit 84.6% · Operating margin change 7 points · 100% evidence Capital efficiency 19.0/25 · ROCE 30% · Operating margin 25% · 100% evidence Valuation 11.7/20 · P/E 19.3× · PEG 1.64 · 100% evidence Relative strength 6.5/20 · Lead over its industry 0.2% · Lead over NIFTY 500 -10.2% · 1 year 33.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 19 + 11.7 + 6.5 = 69.9 · What this means: Earnings are strong; relative strength in its sector is 0.2% and the one-year return is 33.5%. 2. Hindustan Unilever Ltd this page HINDUNILVR · basing · Most evidence points up · 100% evidence 69.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 9.5% · Profit 38% · Operating margin change -2 points · 100% evidence Capital efficiency 15.8/25 · ROCE 28.4% · Operating margin 22% · 100% evidence Valuation 17.2/20 · P/E 39.1× · PEG 0.72 · 100% evidence Relative strength 12.8/20 · Lead over its industry 1% · Lead over NIFTY 500 -9.9% · 1 year -21% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.4 + 15.8 + 17.2 + 12.8 = 69.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Marico Ltd](https://www.sectoralpha.in/stocks/marico-ltd) MARICO · quiet · Most evidence points up · 78% evidence 66.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 25.1% · Profit 15% · Operating margin change 1 points · 83% evidence Capital efficiency 17.9/25 · ROCE 47% · Operating margin 21% · 76% evidence Valuation 6.8/20 · P/E 55.1× · PEG n/a · 50% evidence Relative strength 17.4/20 · Lead over its industry 18.9% · Lead over NIFTY 500 6.5% · 1 year 11.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 24.4 + 17.9 + 6.8 + 17.4 = 66.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) GILLETTE · turning · Evidence leans up · 81% evidence 64.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 8% · Profit 18.4% · Operating margin change -1 points · 88% evidence Capital efficiency 18.1/25 · ROCE 90.7% · Operating margin 29% · 100% evidence Valuation 13.6/20 · P/E 34.5× · PEG 1.7 · 100% evidence Relative strength 10.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -5.5% · 1 year -21.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 23 + 18.1 + 13.6 + 10.1 = 64.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) PGHH · basing · Evidence leans up · 81% evidence 52.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue -1.6% · Profit -4.7% · Operating margin change -9 points · 88% evidence Capital efficiency 17.6/25 · ROCE 157% · Operating margin 19% · 100% evidence Valuation 13.3/20 · P/E 28.1× · PEG 1.77 · 100% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -27.7% · 1 year -48.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.9 + 17.6 + 13.3 + 7.5 = 52.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 6. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) DABUR · basing · Evidence leans up · 81% evidence 51.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 7.4% · Profit 10.9% · Operating margin change 0 points · 88% evidence Capital efficiency 15.8/25 · ROCE 20.3% · Operating margin 20% · 100% evidence Valuation 9.1/20 · P/E 32.7× · PEG 5.04 · 100% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.7% · 1 year -25% · 25% evidence · 0 of 12 weeks ahead Exact sum: 18.2 + 15.8 + 9.1 + 8.8 = 51.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) COLPAL · quiet · Evidence leans up · 85% evidence 50.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Revenue 8.7% · Profit 2.6% · Operating margin change -3 points · 100% evidence Capital efficiency 21.4/25 · ROCE 108% · Operating margin 28% · 100% evidence Valuation 8.4/20 · P/E 31.4× · PEG 6.07 · 100% evidence Relative strength 8.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -17.1% · 1 year -28.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 12.5 + 21.4 + 8.4 + 8.5 = 50.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Emami Ltd](https://www.sectoralpha.in/stocks/emami-ltd) EMAMILTD · basing · Evidence leans down · 96% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.0/35 · Revenue 2.8% · Profit -8.2% · Operating margin change -1 points · 88% evidence Capital efficiency 15.1/25 · ROCE 28.1% · Operating margin 22% · 100% evidence Valuation 8.9/20 · P/E 20.7× · PEG 2.99 · 100% evidence Relative strength 10.1/20 · Lead over its industry -3.2% · Lead over NIFTY 500 -13.6% · 1 year -32.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 9 + 15.1 + 8.9 + 10.1 = 43.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Zydus Wellness Ltd](https://www.sectoralpha.in/stocks/zydus-wellness-ltd) ZYDUSWELL · quiet · Evidence leans down · 96% evidence 39.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 66.3% · Profit -42.5% · Operating margin change -1 points · 88% evidence Capital efficiency 7.7/25 · ROCE 4.9% · Operating margin 17% · 100% evidence Valuation 6.0/20 · P/E 66.5× · PEG 1.75 · 100% evidence Relative strength 12.7/20 · Lead over its industry 12.9% · Lead over NIFTY 500 1.1% · 1 year -2.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 12.8 + 7.7 + 6 + 12.7 = 39.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) GODREJCP · quiet · Evidence leans down · 100% evidence 35.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 12.9% · Profit 8.6% · Operating margin change -1 points · 100% evidence Capital efficiency 10.3/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 4.3/20 · P/E 39.4× · PEG 7.49 · 100% evidence Relative strength 2.9/20 · Lead over its industry -8.6% · Lead over NIFTY 500 -18.5% · 1 year -26.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 10.3 + 4.3 + 2.9 = 35.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) JYOTHYLAB · quiet · Most evidence points down · 96% evidence 34.0 out of 100 Growth Capital Valuation Relative 12. [Polo Queen Industrial and Fintech Ltd](https://www.sectoralpha.in/stocks/polo-queen-industrial-and-fintech-ltd) PQIF · Too little evidence to rank firmly · 33% evidence 39.0 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [FMCG - Personal Care](https://www.sectoralpha.in/sectors/fmcg-personal-care), all 12 compared on one page. ## Which companies are close to HUL in size? HUL is the largest of 12 FMCG - Personal Care companies on Sector Alpha by market value (scores of 30 October 2026). It is the largest. Just below it: Marico, Godrej Consumer Products, Dabur India, Colgate-Palmolive (India), Gillette India and Procter & Gamble Hygiene and Health Care. ### FMCG - Personal Care companies close in size 1. Hindustan Unilever Ltd ₹4,38,105 crore 2. [Marico Ltd](https://www.sectoralpha.in/stocks/marico-ltd) ₹1,04,016 crore 3. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) ₹83,719 crore 4. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) ₹64,856 crore 5. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) ₹43,423 crore 6. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) ₹23,064 crore 7. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) ₹22,239 crore [All 12 FMCG - Personal Care companies, largest first](https://www.sectoralpha.in/sectors/fmcg-personal-care#all-companies) ### Companies close in size in other industries 1. [Kotak Mahindra Bank Ltd](https://www.sectoralpha.in/stocks/kotak-mahindra-bank-ltd) ₹4,59,194 crore · Banks - Private 2. [National Stock Exchange Of India Ltd](https://www.sectoralpha.in/stocks/national-stock-exchange-of-india-ltd) ₹4,41,070 crore 3. Hindustan Unilever Ltd ₹4,38,105 crore 4. [Sun Pharmaceutical Industries Ltd](https://www.sectoralpha.in/stocks/sun-pharmaceutical-industries-ltd) ₹4,26,530 crore · Pharma - Formulators 5. [Adani Ports & Special Economic Zone Ltd](https://www.sectoralpha.in/stocks/adani-ports-special-economic-zone-ltd) ₹4,26,232 crore · Marine Port & Services ## What else do people ask about HUL? ### What is HUL's share price today? Hindustan Unilever Ltd's share price is ₹1,977.10, −14.4% over the past year. The whole company is worth ₹4,64,438 Cr on the market. In the last 52 weeks it traded between ₹1,815 to ₹2,424; today it is 27% of the way up from the low, 5.8% below its 200-day average (as of 4 November 2026). ### What were HUL's latest quarterly results? Hindustan Unilever Ltd reported revenue of ₹18,226 Cr and net profit of ₹2,796 Cr for the Sep 2026 quarter. Revenue rose 14.5% and profit rose 3.8% compared with a year earlier. Earnings per share were ₹11.87. The operating margin was 22.0%, 2.0 percentage points lower than a year earlier (as of 4 November 2026). ### What is HUL's market cap? Hindustan Unilever Ltd's market capitalisation is ₹4,64,438 Cr at a share price of ₹1,977.10. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is HUL performing? Hindustan Unilever Ltd's share price has been falling for 33 weeks. In its latest quarter, revenue rose 14.5% and profit rose 3.8% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 1 week running (as of 4 November 2026). ### Will HUL's share price go up? This page does not forecast Hindustan Unilever Ltd's share price. What it shows instead: the share price is ₹1,977.10, and it has been falling for 33 weeks. Its P/E of 41.5× is higher than 6% of its own last 11 years (as of 4 November 2026). ### Who owns HUL? Promoters own 61.9% of Hindustan Unilever Ltd, foreign institutions 9.3%, domestic institutions 17.1% and the public 11.7% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 2.9 percentage points over 8 quarters (as of 4 November 2026). ### Does HUL have too much debt? No, Hindustan Unilever Ltd has little debt: its debt is 0.03× its equity, and its operating profit is 37 times its interest bill. FY26 borrowings were ₹1,478 Cr against equity of ₹48,739 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is HUL in its business cycle? Hindustan Unilever Ltd's FY26 operating margin was 23.0%, against a 13-year range of 16.0% to 25.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 22.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the HUL story? The main question: yearly earnings per share moved +41.2% while the share price moved −14.4%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is HUL a stock worth studying right now? What the numbers show: Hindustan Unilever Ltd's earnings have grown faster than its share price. Earnings per share grew +41.2% in a year while the price moved −14.4%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a HUL share price forecast for 2026? What management itself guided: FY27 better than FY26, with competitive volume-led revenue and profit growth. ## Lists - Nifty 50 companies: https://www.sectoralpha.in/nifty-50-stocks-list This is research, not advice. We’re not SEBI-registered.